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WHEN considering periodontal disease, it seems prudent, initially, to consider the magnitude of the challenge in 
dentistry. The Adult Dental Health (ADH) Survey 
2009 indicates that the number of people aged 
65 years and over who are edentulous has 
reduced from circa 75 per cent in 1978 to less 
than 25 per cent, hopefully due, in no small part, 
to improvements in the quality care we provide 
our patients. Clearly, not all of the teeth lost are 
solely due to periodontal disease, but the ADH 
Survey tells us that approximately 50 per cent 
of the population has an inflammatory disease 
affecting the periodontal tissues. In addition, 
overall, 45 per cent of adults had periodontal 
(gum) pocketing exceeding 4mm and, no doubt, 
unfortunately, some of these teeth will be lost. 
The conclusions we can draw from the ADH 
Survey in periodontal terms are: 
• Perio disease remains common at a low level.
• Overall, a reduction in mild disease.
• There is a slight increase in the prevalence of 
more severe disease.
• The impact of severe disease is concentrated 
in a small proportion of the population.
• There are associations with a range of health 
behaviours, including smoking, infrequent 
toothbrushing and social gradient (albeit minor).
Clearly, when this information is considered as 
a whole, the prevalence of periodontal conditions 
is significant.
Gingivitis and periodontitis
This was the focus of the fifth European 
Workshop on Periodontology in 2005, where 
the panel considered whether gingivitis and 
periodontitis are a continuum of the same 
inflammatory disease. To summarise their 
conclusions: 
• Gingivitis and periodontitis are a continuum of 
the same inflammatory disease. 
• Not all patients with gingivitis will go on to 
develop periodontitis.
• Chronic inflammatory periodontal disease 
encompasses gingivitis and periodontitis as 
tangible clinical forms. 
So, it would appear that there are two 
patient types. Some patients will retain 
their gingivitis state in perpetuity; they have 
chronic gingivitis, poor oral health and high 
plaque scores, and yet they seem resistant to 
attachment loss. However, others will go on to 
develop periodontitis, which, of course, may, 
unfortunately, lead to tooth loss.  
Importantly, given the evidence reviewed 
at the European Workshop, the precursor 
to periodontitis is always gingivitis, and to 
extrapolate from this, perhaps greater focus 
should be directed by dental care professionals 
on the management of gingivitis so that initiation 
of periodontitis is prevented.
Who’s going to get periodontitis?
Epidemiological data indicates that a significant 
number of patients with gingivitis will develop 
periodontitis, but how do we know who’s at risk?
There are a variety of elements in what we do 
on a daily basis in our clinics that can help us 
try to understand who will develop periodontitis. 
For example, there is the Basic Periodontal 
Examination (BPE) screening tool to help identify 
patients developing periodontal problems. 
Readers should note that there have been some 
recent changes to the BPE system and the latest 
guidance document from the British Society of 
Periodontology can be found at www.bsperio.
org.uk/publications/downloads/39_143748_
bpe2011.pdf. and www.bsperio.org.uk/
publications/downloads/53_085556_executive-
summary-bsp_bspd-perio-guidelines-for-the-
under-18s.pdf.
Of course, the BPE is just one assessment 
tool that identifies individual patients where the 
disease process has already begun. Significant 
efforts have also been made to try to identify 
those individuals at risk of developing disease, 
but that may not have the disease already. Lang 
& Tonetti’s (1996) Bernese spider web/hexagon 
offers a further tool for patient assessment, this 
time from a risk factor perspective. Versions are 
available at www.perio-tools.com/pra/en/.
As the various criteria are entered for each 
patient (for example, age, smoking status, etc.), 
the schematic diagram pictorially represents 
the level of risk that the patient exhibits, 
with the anticipation that any modifiable risk 
factors can be addressed to minimise the risk 
of developing periodontitis. Other excellent 
examples of periodontal risk assessments/
calculators are changing the way we bring these 
factors together in a form that is understandable 
to clinicians and patients alike, reinforcing 
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How will periodontitis progress?
There are many studies that have aimed 
to identify the natural history of periodontal 
diseases and, broadly, there are two patterns of 
disease progression:
1. The linear model where a patient loses 
attachment in a linear manner, which is relatively 
predictable.
2. The discontinuous model where the disease 
activity increases sporadically over time. There 
will be periods of increased and decreased 
disease activity and progressive loss of 
attachment over time in an episodic manner. 
This pattern of disease is much less predictable.
Ultimately, however, there are diverse groups 
of patients whose oral health behaves differently 
and it is very difficult – almost impossible – 
to predict how periodontitis will progress in 
individual patients.
Types of treatment
Currently, oral plaque biofilm disruption is the 
most effective way to treat and prevent both 
conditions, through mechanical and, where 
appropriate, chemical intervention. On a day-
to-day basis, the emphasis is on the patient to 
affect their plaque biofilm (removal or disruption) 
using the variety of homecare products available. 
From a clinician’s perspective, in terms of 
scheduling treatment for patients with chronic 
periodontitis, there are three main approaches 
that have been implemented over the years: 
• Conventional Staged Debridement (CSD), 
which involves scaling and root surface 
debridement over a period of weeks in a 
quadrant-wise or sextant-wise manner.
• Full Mouth Disinfection (FMDis), which 
comprises scaling and root surface debridement 
in the shortest period of time and the use of 
chlorhexidine on the tongue, tonsils and sub-
gingivally with the aim of minimising the bacterial 
load in the various bacterial reservoirs in and 
around the oral cavity.
• Full Mouth Debridement (FMDeb), which is 
essentially the same as the FMDis approach, but 
without the adjunctive use of chlorhexidine.
Which treatment regime is best for patients 
with chronic periodontitis? Thankfully, all of the 
modalities achieve much the same outcomes. 
FMDis and FMDeb do offer slightly better 
statistical results, but whether they are clinically 
significant is debatable. Therefore, all three 
treatment modalities may be recommended 
for chronic periodontitis (without preference), 
provided adequate preventive measures are 
delivered. A different conclusion is conferred 
to patients with aggressive periodontitis where 
FMDeb with the adjunctive use of systemic 
antimicrobials is commonly advocated as the 
preferred non-surgical treatment modality.
Outcomes of treatment?
Treatment outcome is dependent upon many 
factors, including the extent of the initial 
pocketing, location, plaque control and treatment 
quality. Local anatomy is highly significant, for 
example, furcation involvement is also particularly 
important in terms of treatment outcomes. 
Data from Claffey et al (1990) indicates that the 
outcome of periodontal treatment in teeth that 
are furcally involved is considerably worse than 
where teeth have no furcation involved. 
Many patients will require several cycles of 
CSD/FMDis/FMDeb to reduce periodontal 
pocketing to an acceptable level, which is a 
point often overlooked in primary care settings 
where the expectation is that one cycle of 
treatment is enough; often, it won’t be. The 
requirement for multiple treatment cycles 
needs to be communicated to patients so 
that they have realistic expectations relating 
to the time involved and the financial elements 
required to achieve a successful periodontal 
outcome. Of course, the requirements of a 
periodontal maintenance regime also need to be 
communicated fully.
To conclude, there are a significant number 
of patients with chronic gingivitis and, given 
the consensus that this state has the potential 
to deteriorate to chronic periodontitis, the 
management of gingivitis patients should be 
a focus of attention. Positive improvements 
in periodontal health can be provided using a 
variety of treatment approaches, but consistently 
affecting the dental plaque biofilm is key. 
Unfortunately, the pathogenesis of periodontal 
disease is complex, and while there are tools to 
assist clinicians to predict those individuals who 
are likely to have periodontitis, there is currently 
no crystal ball that is 100 per cent accurate. As 
a consequence, patients with periodontitis are a 
significant challenge and outcomes are often like 
a box of chocolates.    n
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